Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuralgia | 10 | 2026 | 22 | 5.840 |
Why?
|
| Nerve Regeneration | 13 | 2026 | 46 | 4.820 |
Why?
|
| Platelet-Rich Plasma | 8 | 2026 | 8 | 3.870 |
Why?
|
| Wound Healing | 6 | 2021 | 88 | 2.600 |
Why?
|
| Axons | 8 | 2025 | 117 | 2.100 |
Why?
|
| Phantom Limb | 3 | 2023 | 3 | 1.900 |
Why?
|
| Ganglia, Spinal | 7 | 2018 | 42 | 1.740 |
Why?
|
| Recovery of Function | 5 | 2025 | 107 | 1.640 |
Why?
|
| Hyperbaric Oxygenation | 5 | 2015 | 34 | 1.490 |
Why?
|
| Peripheral Nerves | 4 | 2025 | 14 | 1.410 |
Why?
|
| Hypothermia, Induced | 5 | 2010 | 27 | 1.160 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2019 | 187 | 1.080 |
Why?
|
| Wounds and Injuries | 3 | 2020 | 193 | 1.050 |
Why?
|
| Sensory Receptor Cells | 3 | 2020 | 34 | 1.020 |
Why?
|
| Schwann Cells | 3 | 2025 | 14 | 0.780 |
Why?
|
| Pressure Ulcer | 2 | 2015 | 6 | 0.740 |
Why?
|
| Spinal Cord | 4 | 2018 | 114 | 0.690 |
Why?
|
| Humans | 35 | 2026 | 43102 | 0.670 |
Why?
|
| Animals | 20 | 2025 | 16992 | 0.670 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2010 | 388 | 0.650 |
Why?
|
| Sural Nerve | 2 | 2011 | 2 | 0.640 |
Why?
|
| Cytokines | 2 | 2019 | 678 | 0.580 |
Why?
|
| Inflammation | 3 | 2019 | 758 | 0.520 |
Why?
|
| Spinal Cord Injuries | 2 | 2010 | 69 | 0.490 |
Why?
|
| Regeneration | 1 | 2015 | 32 | 0.450 |
Why?
|
| Ischemia | 2 | 2006 | 47 | 0.430 |
Why?
|
| Adaptation, Psychological | 1 | 2018 | 420 | 0.430 |
Why?
|
| Chronic Disease | 2 | 2015 | 549 | 0.420 |
Why?
|
| Neurons | 4 | 2019 | 1263 | 0.390 |
Why?
|
| Electric Stimulation | 2 | 2015 | 186 | 0.380 |
Why?
|
| Cranial Irradiation | 1 | 2012 | 4 | 0.370 |
Why?
|
| Radiation Injuries | 1 | 2012 | 23 | 0.370 |
Why?
|
| Ulnar Neuropathies | 1 | 2011 | 1 | 0.360 |
Why?
|
| Pain | 1 | 2015 | 290 | 0.360 |
Why?
|
| Embolism, Air | 1 | 2011 | 4 | 0.350 |
Why?
|
| Medical Errors | 1 | 2011 | 6 | 0.350 |
Why?
|
| Pulmonary Embolism | 1 | 2011 | 38 | 0.340 |
Why?
|
| Brain | 3 | 2019 | 1472 | 0.330 |
Why?
|
| Sciatic Neuropathy | 1 | 2010 | 1 | 0.320 |
Why?
|
| Growth Cones | 2 | 2009 | 12 | 0.320 |
Why?
|
| Sciatic Nerve | 1 | 2010 | 12 | 0.320 |
Why?
|
| Neurosurgical Procedures | 2 | 2007 | 26 | 0.320 |
Why?
|
| Heart Diseases | 1 | 2011 | 112 | 0.320 |
Why?
|
| Chondroitin ABC Lyase | 1 | 2009 | 2 | 0.310 |
Why?
|
| Neurites | 1 | 2009 | 40 | 0.310 |
Why?
|
| Ultrasonography | 1 | 2010 | 135 | 0.310 |
Why?
|
| Nervous System Diseases | 1 | 2009 | 77 | 0.300 |
Why?
|
| Tacrolimus | 1 | 2009 | 16 | 0.290 |
Why?
|
| Brain Injuries | 1 | 2010 | 129 | 0.280 |
Why?
|
| Immunosuppressive Agents | 1 | 2009 | 94 | 0.280 |
Why?
|
| Brain Ischemia | 1 | 2010 | 189 | 0.280 |
Why?
|
| Radial Nerve | 1 | 2007 | 2 | 0.270 |
Why?
|
| Morphine | 1 | 2008 | 69 | 0.270 |
Why?
|
| Transplantation, Autologous | 1 | 2026 | 8 | 0.240 |
Why?
|
| Acid-Base Equilibrium | 1 | 2006 | 8 | 0.240 |
Why?
|
| Models, Animal | 3 | 2015 | 151 | 0.240 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2006 | 58 | 0.240 |
Why?
|
| Cell Communication | 1 | 2006 | 114 | 0.220 |
Why?
|
| Neuroprotective Agents | 2 | 2008 | 269 | 0.220 |
Why?
|
| Adult | 6 | 2026 | 13872 | 0.220 |
Why?
|
| Cell Membrane | 1 | 2006 | 403 | 0.200 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2003 | 30 | 0.200 |
Why?
|
| Extremities | 1 | 2023 | 20 | 0.200 |
Why?
|
| Bacterial Infections | 2 | 2015 | 45 | 0.200 |
Why?
|
| Neovascularization, Physiologic | 2 | 2015 | 80 | 0.190 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2015 | 100 | 0.190 |
Why?
|
| Clinical Trials as Topic | 2 | 2015 | 259 | 0.190 |
Why?
|
| Rats | 5 | 2011 | 3735 | 0.190 |
Why?
|
| Asthma | 1 | 2006 | 416 | 0.180 |
Why?
|
| Prospective Studies | 1 | 2026 | 1600 | 0.180 |
Why?
|
| Male | 7 | 2026 | 23409 | 0.160 |
Why?
|
| Nociceptors | 1 | 2019 | 30 | 0.160 |
Why?
|
| Middle Aged | 3 | 2026 | 12222 | 0.140 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2018 | 14 | 0.140 |
Why?
|
| Electric Stimulation Therapy | 1 | 2018 | 18 | 0.140 |
Why?
|
| Analgesics | 1 | 2018 | 55 | 0.130 |
Why?
|
| Nerve Net | 1 | 2018 | 101 | 0.130 |
Why?
|
| Cell Death | 2 | 2010 | 278 | 0.120 |
Why?
|
| Ligaments | 1 | 2015 | 2 | 0.120 |
Why?
|
| Tendon Injuries | 1 | 2015 | 3 | 0.120 |
Why?
|
| Debridement | 1 | 2015 | 4 | 0.120 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2015 | 14 | 0.120 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2015 | 2 | 0.120 |
Why?
|
| Bandages | 1 | 2015 | 7 | 0.120 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2015 | 28 | 0.110 |
Why?
|
| Administration, Topical | 1 | 2015 | 39 | 0.110 |
Why?
|
| Fractures, Bone | 1 | 2015 | 63 | 0.110 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 107 | 0.110 |
Why?
|
| Light | 1 | 2015 | 185 | 0.110 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2015 | 127 | 0.110 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2015 | 97 | 0.110 |
Why?
|
| Anti-Infective Agents | 1 | 2015 | 75 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2009 | 1621 | 0.100 |
Why?
|
| Tissue Scaffolds | 1 | 2013 | 35 | 0.100 |
Why?
|
| Calcium | 2 | 2009 | 491 | 0.100 |
Why?
|
| Fibroblasts | 1 | 2015 | 281 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2010 | 1766 | 0.100 |
Why?
|
| Time Factors | 2 | 2009 | 1857 | 0.100 |
Why?
|
| Stem Cells | 1 | 2013 | 152 | 0.090 |
Why?
|
| United States | 1 | 2023 | 5205 | 0.090 |
Why?
|
| Fibrin | 1 | 2011 | 10 | 0.090 |
Why?
|
| Necrosis | 1 | 2012 | 54 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 432 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2015 | 434 | 0.090 |
Why?
|
| Subclavian Vein | 1 | 2011 | 2 | 0.090 |
Why?
|
| Vena Cava, Superior | 1 | 2011 | 5 | 0.090 |
Why?
|
| Infusions, Intravenous | 1 | 2011 | 53 | 0.090 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2011 | 21 | 0.090 |
Why?
|
| Central Nervous System Diseases | 1 | 2011 | 32 | 0.090 |
Why?
|
| Young Adult | 1 | 2022 | 5080 | 0.090 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2014 | 298 | 0.080 |
Why?
|
| Collagen | 1 | 2011 | 181 | 0.080 |
Why?
|
| Pain Measurement | 1 | 2011 | 183 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2015 | 1604 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 1070 | 0.080 |
Why?
|
| Wallerian Degeneration | 1 | 2010 | 1 | 0.080 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2010 | 16 | 0.080 |
Why?
|
| Female | 2 | 2026 | 24698 | 0.080 |
Why?
|
| Coculture Techniques | 1 | 2009 | 109 | 0.080 |
Why?
|
| Immunophilins | 1 | 2009 | 5 | 0.070 |
Why?
|
| Substrate Specificity | 1 | 2009 | 219 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 440 | 0.070 |
Why?
|
| Oxidative Stress | 2 | 2006 | 1003 | 0.070 |
Why?
|
| Cell Adhesion | 1 | 2009 | 238 | 0.070 |
Why?
|
| Remission Induction | 1 | 2008 | 19 | 0.070 |
Why?
|
| Models, Neurological | 1 | 2009 | 136 | 0.070 |
Why?
|
| Receptors, Opioid | 1 | 2008 | 40 | 0.070 |
Why?
|
| Immune System | 1 | 2008 | 41 | 0.070 |
Why?
|
| Longitudinal Studies | 1 | 2011 | 1063 | 0.070 |
Why?
|
| Microscopy | 1 | 2008 | 35 | 0.070 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2008 | 38 | 0.070 |
Why?
|
| Anura | 1 | 2008 | 34 | 0.070 |
Why?
|
| Nerve Growth Factors | 1 | 2006 | 34 | 0.060 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 1596 | 0.050 |
Why?
|
| Binding Sites | 1 | 2006 | 671 | 0.050 |
Why?
|
| Paraplegia | 1 | 2003 | 2 | 0.050 |
Why?
|
| Quadriplegia | 1 | 2003 | 4 | 0.050 |
Why?
|
| Intracellular Fluid | 1 | 2003 | 26 | 0.050 |
Why?
|
| Free Radical Scavengers | 1 | 2003 | 64 | 0.050 |
Why?
|
| Neurotoxins | 1 | 2003 | 57 | 0.050 |
Why?
|
| Capsaicin | 1 | 2003 | 28 | 0.050 |
Why?
|
| Receptors, Drug | 1 | 2003 | 61 | 0.050 |
Why?
|
| Mice | 1 | 2010 | 6644 | 0.040 |
Why?
|
| Adolescent | 1 | 2008 | 6081 | 0.030 |
Why?
|
| Disease Management | 1 | 2014 | 70 | 0.030 |
Why?
|
| Child | 1 | 2014 | 3443 | 0.020 |
Why?
|
| Cell Line | 1 | 2003 | 1410 | 0.010 |
Why?
|